Work

Pediatric Rhabdomyosarcoma

Year: 2015

Type: article

Abstract: Rhabdomyosarcoma is the most common soft-tissue sarcoma of childhood, and despite clinical advances, subsets of these patients continue to suffer high levels of morbidity and mortality associated with their disease. Recent genetic and molecular characterization of these tumors using sophisticated genomics techniques, including next-generation sequencing experiments, has revealed multiple areas that can be exploited for new molecularly targeted therapies for this disease.

Source: Critical Reviews™ in Oncogenesis

DOI: 10.1615/critrevoncog.2015013800

Authors: Jack F. Shern, Marielle E. Yohe, Javed Khan

Institutions: National Institutes of Health, Center for Cancer Research

Language: English

Topic: Sarcoma Diagnosis and Treatment

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funder: National Institutes of Health